Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.145
+0.075 (7.01%)
At close: Apr 29, 2025, 4:00 PM
1.130
-0.015 (-1.31%)
After-hours: Apr 29, 2025, 5:28 PM EDT
Allarity Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Allarity Therapeutics.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Allarity Therapeutics.
Recommendation Trends
Rating | Jun '22 | Jul '22 | Aug '22 |
---|---|---|---|
Strong Buy | 1 | 1 | 0 |
Buy | 0 | 0 | 0 |
Hold | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 |
Total | 1 | 1 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 23, 2022 |
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $6,720,000 | Strong Buy | Initiates | $6,720,000 | +586,899,463.32% | May 27, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-47.86
from -15.65
EPS Next Year
-53.24
from -47.86
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | n/a | n/a | 9.0M |
Avg | n/a | n/a | 8.8M |
Low | n/a | n/a | 8.4M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -49.27 | -54.81 | -26.46 |
Avg | -47.86 | -53.24 | -25.70 |
Low | -45.98 | -51.16 | -24.70 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.